Thomas A Ratko

1.1k total citations
32 papers, 813 citations indexed

About

Thomas A Ratko is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Thomas A Ratko has authored 32 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Thomas A Ratko's work include Hematopoietic Stem Cell Transplantation (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Estrogen and related hormone effects (4 papers). Thomas A Ratko is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Estrogen and related hormone effects (4 papers). Thomas A Ratko collaborates with scholars based in United States, Canada and Japan. Thomas A Ratko's co-authors include Carol J. Detrisac, Gary J. Kelloff, Karl Matuszewski, Naomi Aronson, Nancy Dinger, Richard C. Moon, Cathy F. Thomas, R C Moon, Donna A. Wall and Kathleen M Ziegler and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Thomas A Ratko

32 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A Ratko United States 16 255 175 172 151 143 32 813
Akihiro Iguchi Japan 18 345 1.4× 81 0.5× 173 1.0× 149 1.0× 219 1.5× 84 1.0k
Kendall P. Crookston United States 14 232 0.9× 42 0.2× 183 1.1× 52 0.3× 53 0.4× 36 776
H. Bartels Germany 18 351 1.4× 70 0.4× 143 0.8× 55 0.4× 201 1.4× 42 924
A Lindemann Germany 13 395 1.5× 103 0.6× 114 0.7× 46 0.3× 279 2.0× 36 915
W.Y. Au China 14 297 1.2× 33 0.2× 176 1.0× 68 0.5× 134 0.9× 37 713
G. Ehninger Germany 15 463 1.8× 57 0.3× 162 0.9× 110 0.7× 170 1.2× 56 859
Michael Daskalakis Switzerland 18 494 1.9× 100 0.6× 677 3.9× 96 0.6× 245 1.7× 55 1.5k
Mogens Krogh Jensen Denmark 20 463 1.8× 141 0.8× 281 1.6× 252 1.7× 175 1.2× 58 1.1k
Nicholas Wickham Australia 16 292 1.1× 64 0.4× 256 1.5× 35 0.2× 130 0.9× 35 804
Noga Manny Israel 18 369 1.4× 109 0.6× 130 0.8× 30 0.2× 78 0.5× 49 1.2k

Countries citing papers authored by Thomas A Ratko

Since Specialization
Citations

This map shows the geographic impact of Thomas A Ratko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A Ratko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A Ratko more than expected).

Fields of papers citing papers by Thomas A Ratko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A Ratko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A Ratko. The network helps show where Thomas A Ratko may publish in the future.

Co-authorship network of co-authors of Thomas A Ratko

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A Ratko. A scholar is included among the top collaborators of Thomas A Ratko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A Ratko. Thomas A Ratko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ratko, Thomas A, et al.. (2015). Gene expression analysis for prostate cancer management.. PubMed. 29(9). 1–9. 1 indexed citations
2.
Ratko, Thomas A, et al.. (2013). Figure 1, PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) diagram depicting the flow of articles through this Technical Brief. 2 indexed citations
3.
Ratko, Thomas A, et al.. (2013). Electronic Database Search Strategies. 1 indexed citations
4.
Ratko, Thomas A, et al.. (2013). Enzyme-Replacement Therapies for Lysosomal Storage Diseases. 20 indexed citations
5.
Oliansky, Denise M, Bruce M. Camitta, Paul S. Gaynon, et al.. (2011). Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review. Biology of Blood and Marrow Transplantation. 18(4). 505–522. 77 indexed citations
6.
Oliansky, Denise M, Richard A. Larson, Daniel J. Weisdorf, et al.. (2011). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review. Biology of Blood and Marrow Transplantation. 18(1). 18–36.e6. 32 indexed citations
7.
Samson, David J, Thomas A Ratko, Barbara M Rothenberg, et al.. (2010). Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer. Europe PMC (PubMed Central). 11 indexed citations
8.
Shander, Aryeh, Lawrence T. Goodnough, Thomas A Ratko, et al.. (2005). Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven®) therapy. 30(11). 644–658. 41 indexed citations
9.
Marks, David S., et al.. (2004). 1040-73 Financial impact of drug-eluting stents: The US academic experience. Journal of the American College of Cardiology. 43(5). A402–A402. 1 indexed citations
10.
Ratko, Thomas A, et al.. (2003). Clinical gene therapy for nonmalignant disease. The American Journal of Medicine. 115(7). 560–569. 26 indexed citations
11.
Ratko, Thomas A, Harold A. Oberman, Kendall P. Crookston, et al.. (2001). Evidence‐based recommendations for the use of WBC‐reduced cellular blood components. Transfusion. 41(10). 1310–1319. 45 indexed citations
12.
Chen, Connie, et al.. (2000). A Multicenter Drug Use Surveillance of Intravenous Immunoglobulin Utilization in US Academic Health Centers. Annals of Pharmacotherapy. 34. 295–299. 1 indexed citations
13.
Matuszewski, Karl, et al.. (1995). Surveillance of Colony-Stimulating Factor use in us Academic Health Centers. Annals of Pharmacotherapy. 29(5). 475–480. 10 indexed citations
14.
Ratko, Thomas A. (1995). Recommendations for Off-Label Use of Intravenously Administered Immunoglobulin Preparations. JAMA. 273(23). 1865–1865. 87 indexed citations
15.
Ratko, Thomas A, Carol J. Detrisac, Rajendra G. Mehta, Gary J. Kelloff, & R C Moon. (1991). Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.. PubMed. 51(2). 481–6. 66 indexed citations
16.
Ratko, Thomas A, et al.. (1990). Interspecies analysis of the chemopreventive efficacy of dietary alpha-difluoromethylornithine.. PubMed. 10(1). 67–72. 20 indexed citations
17.
Ratko, Thomas A, Richard Braun, John M. Pezzuto, & Craig W. Beattie. (1988). Estrous cycle modification of rat mammary gland DNA alkylation by N-methyl-N-nitrosourea.. PubMed. 48(11). 3090–3. 13 indexed citations
18.
Braun, Richard, Thomas A Ratko, John M. Pezzuto, & Craig W. Beattie. (1987). Estrous cycle modification of rat uterine DNA alkylation by N-methyl-N-nitrosourea. Cancer Letters. 37(3). 345–352. 3 indexed citations
19.
Ratko, Thomas A & John M. Pezzuto. (1985). Improved fluorometric method for quantitative high-performance liquid chromatographic analysis of methylated guanine derivatives in DNA. Journal of Chromatography A. 324(2). 484–488. 6 indexed citations
20.
Ratko, Thomas A & Craig W. Beattie. (1985). Estrous cycle modification of rat mammary tumor induction by a single dose of N-methyl-N-nitrosourea.. PubMed. 45(7). 3042–7. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Iguchi Breakdown of academic impact, for papers by Kendall P. Crookston Breakdown of academic impact, for papers by H. Bartels Breakdown of academic impact, for papers by A Lindemann Breakdown of academic impact, for papers by W.Y. Au Breakdown of academic impact, for papers by G. Ehninger Breakdown of academic impact, for papers by Michael Daskalakis Breakdown of academic impact, for papers by Mogens Krogh Jensen Breakdown of academic impact, for papers by Nicholas Wickham Breakdown of academic impact, for papers by Noga Manny
Rankless by CCL
2026